VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF)
(“
VIVO” or the “
Company”) is
pleased to announce that its wholly-owned subsidiary, Harvest
Medicine Inc. (“
Harvest Medicine” or
“
HMED”), has completed the acquisition of Trauma
Healing Centres (“
THC”) from Organigram Holdings
Inc..
THC is a multi-disciplinary clinic network that
has been providing medical cannabis care and education to thousands
of patients in Nova Scotia, New Brunswick and Ontario since 2014.
THC specializes in patient assessment and medical cannabis
prescribing and also offers patients individualized,
multi-disciplinary wellness plans.
Both THC and Harvest Medicine share a deeply
ingrained patient-centric approach to care. The transition of THC
to Harvest Medicine offers THC the opportunity to flourish under an
experienced medical management team, wholly committed to the
day-to-day operation of exceptional medical cannabis clinics.
“We are pleased to see two excellent
organizations join forces to offer Canadian medical cannabis
patients access to outstanding care,” says Greg Engel, CEO,
Organigram. “We are proud of our relationship with THC and look
forward to seeing the outstanding team at Harvest take the delivery
of care to the next level.”
“THC’s reputation with the veteran community as
a trusted resource and partner, and its commitment to providing
exceptional patient care make it an excellent fit with Harvest
Medicine,” stated Shekhar Parmar, President of HMED. “This
acquisition accelerates our national expansion plans and we look
forward to building on THC’s success in these markets and
continuing to ensure patients have improved access to our
best-in-class services.”
The transaction will see HMED acquire 100% of
the issued and outstanding shares of THC from Organigram. The total
purchase price for the shares will be $1,200,000, to be satisfied
by the issuance of common shares in the capital of VIVO at a price
per share equal to the ten trading day volume weighted average
price immediately prior to the closing of the transaction.
With this acquisition HMED will add locations in
Nova Scotia, New Brunswick, and Ontario to its existing network of
medical cannabis clinics in Edmonton and Calgary. The
transaction will also add another 4,500 patients to HMED’s existing
patient base, bringing the total number of active HMED patients to
above 22,000.
“Our physical locations and our soon to be
released telemedicine platform, HMED Connect, complement each other
to ensure enhanced seamless service, flexibility and greater
scalability for HMED and its patients” said Mr. Parmar. “Our vision
is to transform the medical cannabis experience for patients and
physicians and be recognized as the trusted leader in medical
cannabis care across the country.”
About Trauma Healing
Centers
Trauma Healing Centers is a resource center for
anyone suffering from post-traumatic stress disorder (PTSD),
trauma, chronic pain, cancer treatment or other disabling illness
including veterans, RCMP, first responders and civilians. Our team
of dedicated professionals will work with patients on an individual
basis to provide a wellness plan to enhance their quality of
life.
About Harvest Medicine
Harvest Medicine (“HMED”, www.hmed.ca) is an
education focused, patient-centric, network of specialty medical
cannabis clinics where patients receive best in class education,
care, advice and follow-up support as they approach
cannabinoid-based medicine.
Growing to over 15,000 active patients in under
18 months, HMED is one of Canada’s most successful and fastest
growing cannabis clinic networks. With the imminent launch of HMED
Connect, a free telemedicine app and service, and the acquisition
of Trauma Healing Centres, HMED is focused on aggressively
expanding its effective and highly scalable model across the
country.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing the highest-quality,
indoor-grown cannabis for patients and adult recreational consumers
in Canada, as well as developing international business
partnerships to extend the company’s global footprint. In
anticipation of the legal adult use recreational cannabis in
Canada, Organigram has developed a portfolio of brands including
The Edison Cannabis Company, Ankr Organics and Trailer Park Buds.
Organigram’s primary facility is located in Moncton, New Brunswick
and the Company is regulated by the Access to Cannabis for Medical
Purposes Regulations (“ACMPR”).
About VIVO Cannabis™
VIVO, based in Napanee, Ontario, is recognized for trusted,
high-quality products and services. It holds production and sales
licences from Health Canada and operates world-class indoor
cultivation facilities with proprietary plant-growing technology.
VIVO has a collection of premium brands targeting unique customer
segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and
Lumina™. In August 2018, VIVO acquired Canna Farms Limited, a
premium cannabis company based in Hope, British Columbia. Canna
Farms was B.C.’s first Licensed Producer and has several years of
craft cultivation experience and expertise, as well as a
significant patient base and positive cash flow. The Company is
significantly expanding its production capacity and pursuing
partnership and product development opportunities domestically, as
well as in select international markets, including Germany and
Australia. VIVO also operates Harvest Medicine, a patient-centric
and highly scalable network of specialty medical cannabis clinics
as well as a soon to be released free telemedicine app. VIVO has a
healthy balance sheet with approximately $100 million in cash and
is well-positioned to accelerate the growth of our business, in
Canada and internationally.
Disclaimer for Forward-Looking Information
This news release contains forward-looking
statements, including statements regarding the financial
performance, reputation and impact of acquiring Trauma Healing
Centres, as well as the successful launch of HMED Connect, the
potential benefits to patients of using these services, and the
potential benefit to HMED of acquiring these additional clinics.
The forward-looking statements in this release are based on
certain assumptions and involve known and unknown risks and
uncertainties and other factors that could cause actual events to
differ materially from current assumptions and expectations,
including that the acquired locations will continue to be viable
business operations, patients may not find the services helpful and
regulations around medical cannabis education and use may change.
These forward-looking statements should not be read as guarantees
of future performance or results. Such statements involve known and
unknown risks, uncertainties and other factors that may cause
actual results, performance or achievements to be materially
different from those implied by such statements, including that
there may be regulatory impediments to the success of medical
cannabis clinics and HMED Connect; and that there may be
operational and technical challenges integrating Trauma Health
Centres processes with Harvest Medicine and HMED Connect. A more
complete discussion of the risks and uncertainties facing the
Company appears in the Company’s Annual Information Form for the
year ended December 31, 2017 and other continuous disclosure
filings, which are available on SEDAR at www.sedar.com.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
news release. The Company disclaims any intention or obligation to
update or revise any forward-looking statements as a result of new
information or future events, or for any other reason, other than
as required by applicable securities laws.
More Information
Barry Fishman, CEO: barry.fishman@vivocannabis.com
Michael Bumby, CFO: michael.bumby@vivocannabis.com
Shekhar Parmar, CEO, HMED sp@hmed.ca
VIVO Website: vivocannabis.com
VIVO Cannabis (TSXV:VIVO)
Historical Stock Chart
Von Jan 2025 bis Feb 2025
VIVO Cannabis (TSXV:VIVO)
Historical Stock Chart
Von Feb 2024 bis Feb 2025